Publications

Sykes
1. Sykes M, Wood K, Sachs DH. Transplantation Immunology. In: Paul WE, editor. Fundamental Immunology (7th edition). Philadelphia, PA: Lippincott Williams & Wilkins Publishers; 2013. 46: 1154-1199.


2. Kawai T, Sachs DH, Sykes M, Cosimi AB, for the Immune Tolerance Network. HLA mismatched renal transplantation without maintenance immunosuppression-an update. Letter to the Editor. May 9, 2013 N Engl J Med 2013; 368:1850-1852. PMID: 23656665 PMC3760499.


3. Sachs DH, Kawai T, Sykes M. Induction of Tolerance Through Mixed Chimerism. In: Turka L, Wood K, editors. Cold Spring Harbor Perspectives; 2013. 2014 Jan 1;4(1):a015529. doi: 10.1101/cshperspect.a015529.


4. Haspot F, Li HW, Lucas CL, Fehr T, Beyaz S, Sykes M. Allospecific rejection of MHC class I-deficient bone marrow by CD8 T cells. American Journal of Transplantation, 2014 Jan 14(1): 49-58. doi: 10.1111/ajt.12525. PMID: 24304495. PMCID: PMC4045013


5. Griesemer A, Yamada K, Sykes M. Xenotransplantation: Immunological hurdles and progress toward tolerance. Immunological Reviews; 2014 Mar;258(1):241-58. doi: 10.1111/imr.12152. PMID: 24517437. PMCID: PMC4023346.


6. Sykes M. Transplantation: Moving to the Next Level. Immunological Reviews; 2014. 2014 Mar;258(1):5-11. doi: 10.1111/imr.12161. PMID: 24517422. PMCID: PMC4038030.


7. Sykes M. Transplantation Immunology. In: The Cecil Text Book of Medicine, 25th Edition. (Eds), Goldman L, Ausiello, D. Philadelphia, PA; Saunders Elsevier; 2014; (In Press)


8. Kalscheuer H, Onoe T, Dahmani A, Holzl M, Yamada K, Sykes M. Xenograft tolerance and immune function of human T cells developing in pig thymus xenografts. Journal of Immunology, 2014 Apr 1;192(7):3442-50. doi: 10.4049/jimmunol.1302886. PMID: 24591363. PMCID: PMC3983999.


9. Li H, Yang YG, Sykes M. Thymic education of human T cells and regulatory T cell development in humanized mice. In: Humanized Mice for HIV Research; Poluektova LY, Garcia-Martinez JV, Koyanagi Y, Manz MG, Tager AM (Ed.), New York, NY, Springer Science+Business Media; 2014; 10: (page number to be determined) (In Press)


10. Kawai T, Sachs DH, Sprangers B, Spitzer T, Saidman S, Zorn E, Tolkoff-Rubin N, Preffer F, Crisalli K, Gao B, Wong W, Morris H, LoCascio S, Sayre P, Shonts B, Williams W, Smith R, Colvin R, Sykes M, Cosimi A. Long-Term Results in Recipients of Combined HLA-Mismatched Kidney and Bone Marrow Transplantation Without Maintenance Immunosuppression. American Journal of Transplantation. 2014 June 5; XX:1-13. doi: 10.1111/ajt.12731. PMID: 24903438

Mapara
1. Phase 1/2 Study of Ocaratuzumab, an Fc-Engineered Humanized Anti-CD20 Monoclonal Antibody, in Low-Affinity FcγRIIIa Patients with Previously Treated Follicular Lymphoma. Ganjoo KN, de Vos S, Pohlman BL, Flinn IW, Forero-Torres A, Enas NH, Cronier DM, Dang NH, Foon KA, Carpenter SP, Slapak CA, Link BK, Smith MR, Mapara MY, Wooldridge JE. Leuk Lymphoma. 2014 Jul 14:1-7. [Epub ahead of print] PMID: 24717109 [PubMed - as supplied by publisher] PMCID IN PROGRESS

2. Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial. Choi SW, Braun T, Chang L, Ferrara JL, Pawarode A, Magenau JM, Hou G, Beumer JH, Levine JE, Goldstein S, Couriel DR, Stockerl-Goldstein K, Krijanovski OI, Kitko C, Yanik GA, Lehmann MH, Tawara I, Sun Y, Paczesny S, Mapara MY, Dinarello CA, DiPersio JF, Reddy P. Lancet Oncol. 2014 Jan;15(1):87-95. doi: 10.1016/S1470-2045(13)70512-6. Epub 2013 Nov 30. PMID: 24295572 [PubMed - indexed for MEDLINE] PMCID: PMC4103793

3. Reprogramming donor T cells for adoptive immunotherapy. Mapara MY. Immunotherapy. 2013 Dec;5(12):1287-9. doi: 10.2217/imt.13.139. No abstract available. PMID: 24283838 [PubMed - indexed for MEDLINE] PMCID IN PROGRESS

4. IL-12hi rapamycin-conditioned dendritic cells mediate IFN-γ-dependent apoptosis of alloreactive CD4+ T cells in vitro and reduce lethal graft-versus-host disease. Stenger EO, Rosborough BR, Mathews LR, Ma H, Mapara MY, Thomson AW, Turnquist HR. Biol Blood Marrow Transplant. 2014 Feb;20(2):192-201. doi: 10.1016/j.bbmt.2013.11.007. Epub 2013 Nov 12. PMID: 24239650 [PubMed - in process] PMCID: PMC3964782

5. Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial. Armand P, Nagler A, Weller EA, Devine SM, Avigan DE, Chen YB, Kaminski MS, Holland HK, Winter JN, Mason JR, Fay JW, Rizzieri DA, Hosing CM, Ball ED, Uberti JP, Lazarus HM, Mapara MY, Gregory SA, Timmerman JM, Andorsky D, Or R, Waller EK, Rotem-Yehudar R, Gordon LI. J Clin Oncol. 2013 Nov 20;31(33):4199-206. doi: 10.1200/JCO.2012.48.3685. Epub 2013 Oct 14. PMID: 24127452 [PubMed - indexed for MEDLINE] PMCID IN PROGRESS

6. The quest for the optimal conditioning regimen: some answers, more questions. Mapara MY. Biol Blood Marrow Transplant. 2013 Sep;19(9):1275-6. doi: 10.1016/j.bbmt.2013.07.011. Epub 2013 Jul 25. No abstract available. PMID: 23892048 [PubMed - indexed for MEDLINE] PMCID IN PROGRESS

7. Lenalidomide-induced upregulation of CXCR4 in CD34+ hematopoietic cells, a potential mechanism of decreased hematopoietic progenitor mobilization. Li S, Fu J, Ma H, Mapara MY, Lentzsch S. Leukemia. 2013 Jun;27(6):1407-11. doi: 10.1038/leu.2012.323. Epub 2012 Nov 9. No abstract available. PMID: 23138185 [PubMed - indexed for MEDLINE] PMCID IN PROGRESS

8. Longitudinal bone marrow evaluations for myelodysplasia in patients with myeloma before and after treatment with lenalidomide. Monaghan SA, Dai L, Mapara MY, Normolle DP, Gollin SM, Lentzsch S. Leuk Lymphoma. 2013 Sep;54(9):1965-74. doi: 10.3109/10428194.2012.755177. Epub 2013 Jan 28. PMID: 23216269 [PubMed - indexed for MEDLINE] PMCID IN PROGRESS

9. PDLIM2 restricts Th1 and Th17 differentiation and prevents autoimmune disease. Qu Z, Fu J, Ma H, Zhou J, Jin M, Mapara MY, Grusby MJ, Xiao G. Cell Biosci. 2012 Jun 25;2(1):23. doi: 10.1186/2045-3701-2-23. PMID: 22731402 [PubMed] PMCID: PMC3543335

10. Combination of bendamustine, lenalidomide, and dexamethasone (BLD) in patients with relapsed or refractory multiple myeloma is feasible and highly effective: results of phase 1/2 open-label, dose escalation study. Lentzsch S, O'Sullivan A, Kennedy RC, Abbas M, Dai L, Pregja SL, Burt S, Boyiadzis M, Roodman GD, Mapara MY, Agha M, Waas J, Shuai Y, Normolle D, Zonder JA. Blood. 2012 May 17;119(20):4608-13. doi: 10.1182/blood-2011-12-395715. Epub 2012 Mar 26. PMID: 22451423 [PubMed - indexed for MEDLINE] Free PMC Article PMCID: PMC3392072

11. Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity. Stenger EO, Turnquist HR, Mapara MY, Thomson AW. Blood. 2012 May 31;119(22):5088-103. doi: 10.1182/blood-2011-11-364091. Epub 2012 Mar 7. Review. PMID: 22403259 [PubMed - indexed for MEDLINE] Free PMC Article PMCID: PMC3369606

Creusot
1. Yip L, Creusot RJ, Pager CT, Sarnow P, Fathman CG (2013) Reduced DEAF1 function during Type 1 diabetes inhibits translation in lymph node stromal cells by suppressing Eif4g3. J. Mol. Cell. Biol. 5(2): 99-110. PMID: 22923498 [PubMed - indexed for MEDLINE] PMCID: PMC3604916

2. Creusot RJ, Giannoukakis, N, Trucco M, Clare-Salzler MJ, Fathman CG (2014) It’s time to bring dendritic cell therapy to Type 1 Diabetes. Diabetes 63(1): 20-30. PMID: 24357690 [PubMed - indexed for MEDLINE] PMCID: PMC3968436

3. Creusot RJ (2013) Initiating type I diabetes: new suspects in the lineup. Nature Med. 19(1): 18-20. PMID: 23296002 [PubMed - indexed for MEDLINE] PMCID IN PROGRESS

4. Creusot RJ, Moraga I (2013) Superkines: cytokines displaying better targeted functions. Med. Sci (Paris) 29(4): 345-9. PMID: 23621926 [PubMed - indexed for MEDLINE] PMCID IN PROGRESS

Fujisaki
1. Miller PG, Al-Shahrour F, Hartwell KA, Chu LP, Järås M, Puram RV, Puissant A, Callahan KP, Ashton J, McConkey ME, Poveromo LP, Cowley GS, Kharas MG, Labelle M, Shterental S, Fujisaki J, Silberstein L, Alexe G, Al-Hajj MA, Shelton CA, Armstrong SA, Root DE, Scadden DT, Hynes RO, Mukherjee S, Stegmaier K, Jordan CT, and Ebert BL. In Vivo RNA Interference Screening Identifies a Leukemia-Specific Dependence on Integrin Beta 3 Signaling. Cancer Cell 2013 24(1):45-58. PMID: 23770013 [PubMed - indexed for MEDLINE] PMCID: PMC3746037

2. Miller PG, Al-Shahrour F, Hartwell KA, Chu LP, Järås M, Puram RV, Puissant A, Callahan KP, Ashton J, McConkey ME, Poveromo LP, Cowley GS, Kharas MG, Labelle M, Shterental S, Fujisaki J, Silberstein L, Alexe G, Al-Hajj MA, Shelton CA, Armstrong SA, Root DE, Scadden DT, Hynes RO, Mukherjee S, Stegmaier K, Jordan CT, and Ebert BL. In Vivo RNA Interference Screening Identifies a Leukemia-Specific Dependence on Integrin Beta 3 Signaling. Cancer Cell 2013 24(1):45-58. PMID: 23770013 [PubMed - indexed for MEDLINE] PMCID: PMC3746037

3. Fujisaki J. Tregs provide immune privilege to the hematopoietic stem cell niche. Infection, inflammation, and infection. 2013 Jan 42(4), 31-34

Snoeck
1. Huang SX, Islam MN, O’Neill J, Hu Z, Yang Y-Y, Chen Y-W, Green MD, Mumau M, Vunakc-Novakovic G, Bhattacharya J, Snoeck HW. (2014) Highly efficient generation of lung and airway epithelial cells from human pluripotent stem cells. Nat Biotechnol., 32:84-91. PMID: 24291815 [PubMed - in process] PMCID: PMC4101921

2. Kamezaki K, Snoeck HW. (2014) Differential requirement of wild-type Flt3 in leukemic stem cells which is not reflected in vitro assays for leukemic stem cells. Exp Hematol, 32:84-91.

3. Baker SJ, Ma’ayan A, Lieu YK, John P, Reddy MVR, Chen EY, Duan Q, Snoeck HW, Reddy EP. (2014) B-myb is Essential Regulator of Hematopoietic Stem Cell and Myeloid Progenitor Cell Development. Proc. Natl. Acad Sci USA, 111:3122-3127. PMID: 24516162 [PubMed - indexed for MEDLINE] PMCID: PMC3939923

4. Green M, Huang S, Stem cells of the respiratory system: From identification to differentiation into functional epithelium. Bioessays. 35:261-270. Snoeck HW. (2013) PMID: 23175215 [PubMed - indexed for MEDLINE] PMCID IN PROGRESS

5. Snoeck HW. Current state of the art in the generation of anterior foregut derivatives from pluripotent stem cells. Stem Cells Handbook, 2nd Edition (Springer).

6. Snoeck HW. (2013). Aging of the hematopoietic system. Current Opin. Hematol. 20:355-361. PMID: 23739721 [PubMed - indexed for MEDLINE] PMCID IN PROGRESS

Chen
1. Liao S, Mei J, Song W, Chi S, Liu Y, Chen X, Deng S. The impact of the International Association of Diabetes and Pregnancy Study Groups (IADPSG) fasting glucose diagnostic criterion on the prevalence and outcomes of gestational diabetes mellitus in Han Chinese women. Diabetic Medicine 2014; 31(3)341-51; Epub 2013 Nov 22 PMID: 24152069 [PubMed - in process] PMCID IN PROGRESS

2. Rink SJ, McMahon MK, Zhang X, Chen X, Mirkin AC, Thaxton SC, Kaufman DB. IB kinase- knockdown by spherical nucleic acid conjugates prevents cytokine-induced injury and enhances islet graft survival. Transplantation 2013; 96(10):877-884 . PMID: 24247900 [PubMed - indexed for MEDLINE] PMCID: PMC3839058

3. Chen X. Visualizing the Location and the Dynamics of Gene Expression in Living Animals through Bioluminescence Imaging. In: Methods in Cell Biology, Volume 113: Laboratory Methods in Cell Biology: Imaging. Elsevier, 2013, 113:39-49. PMID: 23317896 [PubMed - indexed for MEDLINE] PMCID IN PROGRESS

Duran-Struuck
BOOK CHAPTER
Bram V Lutton and Raimon Duran-Struuck. “Immunogenicity vs Immunomodulation of Perinatal Stem Cells”. In:Perinatal Stem Cells. Ed K.Cetrulo, CL Cetrulo, RR Taghizadeh. Wiley Blackwell 2013.
MANUSCRIPTS
1. Vascularized composite allograft tolerance across MHC barriers in a large animal model. Leonard DA, Kurtz JM, Mallard C, Albritton A, Duran-Struuck R, Farkash EA, Crepeau R, Matar A, Horner BM, Randolph MA, Sachs DH, Huang CA, Cetrulo CL Jr. Am J Transplant. 2014 Feb;14(2):343-55. doi: 10.1111/ajt.12560. Epub 2014 Jan 9. PMID: 24405666 [PubMed - in process] PMCID: PMC3971524

2. Increased levels of anti-non-Gal IgG following pig-to-baboon bone marrow transplantation correlate with failure of engraftment. Liang F, Wamala I, Scalea J, Tena A, Cormack T, Pratts S, Duran-Struuck R, Elias N, Hertl M, Huang CA, Sachs DH. Xenotransplantation. 2013 Nov-Dec;20(6):458-68. doi: 10.1111/xen.12065. Epub 2013 Oct 29. PMID: 24289469 [PubMed - in process] PMCID: PMC3848062

3. Development of a diphtheria toxin-based recombinant porcine IL-2 fusion toxin for depleting porcine CD25+ cells. Peraino JS, Schenk M, Li G, Zhang H, Farkash EA, Sachs DH, Huang CA, Duran-Struuck R, Wang Z. J Immunol Methods. 2013 Dec 15;398-399:33-43. doi: 10.1016/j.jim.2013.09.006. Epub 2013 Sep 18. PMID: 24055128 [PubMed - indexed for MEDLINE] PMCID: PMC3840057

4. Leukapheresis protocol for nonhuman primates weighing less than 10 kg. Pathiraja V, Matar AJ, Gusha A, Huang CA, Duran-Struuck R. J Am Assoc Lab Anim Sci. 2013 Jan;52(1):70-7. PMID: 23562036 [PubMed - indexed for MEDLINE] PMCID: PMC3548204

5. A truncated diphtheria toxin based recombinant porcine CTLA-4 fusion toxin. Peraino JS, Schenk M, Zhang H, Li G, Hermanrud CE, Neville DM Jr, Sachs DH, Huang CA,Duran-Struuck R, Wang Z. J Immunol Methods. 2013 May 31;391(1-2):103-11. doi: 10.1016/j.jim.2013.02.015. Epub 2013 Mar 5. PMID: 23470981 [PubMed - indexed for MEDLINE] PMCID: PMC368805

Wong
1. Porcheray F, Fraser JW, Gao B, McColl A, DeVito J, Dargon I, Helou Y, Wong W, Girouard TC, Saidman SL, Colvin RB, Palmisano A, Maggiore U, Vaglio A, Smith RN, Zorn E. Polyreactive antibodies developing amidst humoral rejection of human kidney grafts bind apoptotic cells and activate complement. Am J Transplant. 2013 Oct;13(10):2590-600.

2. Ferdman J, Porcheray F, Gao B, Moore S, Devito J, Dougherty S, Thomas M, Farkash E, Elias N, Kawai T, Malek SY, Tullius S, Wong W, Zorn E. Expansion and somatic hypermutation of B cell clones in rejected human kidney grafts. Transplantation, 2014 May 12 [epub]

3. Gao B, Moore C, Porceray F, Rong C, Abidoglu C, DeVito J, Paine R, Girouard TC, Saidman SL, Schoenfeld D, Levin B, Wong W, Elias N, Schuetz C, Rosales I, Fu Y, Zorn E. Am J Transplant, in press

Griesemer
1. Samstein B, Cherqui D, Guarrera J, Griesemer A, Halazun KJ, Kato T, Emond JE. Totally laparoscopic full left hepatectomy for living donor liver transplantation in adolescents and adults. Am J Transplant. 2013 Sept: 13: 2462–2466. PMID: 24034709

2. Griesemer A, Yamada K, Sykes M. Xenotransplantation: immunological hurdles and progress toward tolerance. Immunological Reviews. Immunol Rev. 2014 Mar;258(1):241-58. PMID: 24517437

3. Weiner J, Wu J, Martinez M, Lobritto S, Ovchinsky N, Rohde C, Griesemer A, Kato T. The use of bi-planar tissue expanders to augment abdominal domain in a pediatric intestinal transplant recipient. Pediatric Transplantation. 2014 Aug: 18(5): E174–E179, PMID: 25041331.

4. Halazun KJ, Patzer RE, Rana AA, Verna EC, Griesemer AD, Parsons RF, Samstein B, Guarrera JV, Kato T, Brown RS Jr, Emond JC. Standing the test of time: Outcomes of a decade of prioritizing patients with HCC, results of the UNOS natural geographic experiment. Hepatology. 2014 Jun 20. PMID: 24954365

Yang
1. Wang Y, Wang H, Bronson R, Fu Y, Yang YG*. Rapid dendritic cell activation and resistance to allotolerance induction in anti-CD154-treated mice receiving CD47-deficient donor-specific transfusion. Cell Transplant 2014;23(3):355-63. 2013 Jan 2. [Epub ahead of print] PMID: 23295133; PMCID: PMC3732805

2. Wu X, Huang H, Wang C, Lin S, Huang Y, Wang Y, Liang G, Yan Q, Xiao J, Wu J1, Yang YG, Li X. Identification of a novel peptide that blocks basic fibroblast growth factor-mediated cell proliferation, Oncotarget. 2013;10:1819-28

3. Wang Y, Wang H, Xia J, Liang T, Wang G, Li X, Yang YG*. Activated CD8 T cells acquire NK1.1 expression and preferentially locate in the liver in mice after allogeneic hematopoietic cell transplantation. Immunology Letters 2013 Feb;150(1-2):75-8. PMID: 23291124; PMCID: PMC3602380

4. Navarro-Alvarez N, Yang YG*. Lack of CD47 on donor hepatocytes promotes innate immune cell activation and graft loss: a potential barrier to hepatocyte xenotransplantation. Cell Transplant 2014;23(3):345-54. 2013 Feb 7. [Epub ahead of print] PMID: 23394628; PMCID: PMC3751988

5. Huang SXL, Islam MN, O’Neil J, Hu Z, Yang YG, Chen YW, Mumau M, Green MD, Vunjak-Novakovic G, Battachariya J, Snoeck HW. Efficient generation of lung and airway epithelial cells from human pluripotent stem cells. Nat Biotechnol. 2014;32(1):84-91. doi: 10.1038/nbt.2754. Epub 2013 Dec 1.

6. Rong Z, Wang M, Hu Z, Stradner M, Zhu S, Kong H, Yi H, Goldrath A, Yang YG, Xu Y, Fu X. An effective approach to prevent immune rejection of human ESC-derived allografts. Cell Stem Cell 2014 Jan 2;14(1):121-30. doi: 10.1016/j.stem.2013.11.014. PMCID: PMC4023958.

7. Wang H, Yang YG. The complex and central role of interferon- in graft-versus-host disease and graft-versus-tumor activity. Immunol Rev. 2014 Mar;258(1):30-44. NIHMSID # 579492

Farber
1. Sathaliyawala, T., Kubota, M., Yudanin, N., Turner, D., Camp, P., Thome, J.C., Bickham, K.L., Lerner, H., Goldstein, M., Sykes, M., Kato, T and Farber, D.L. (2013) Distribution and compartmentalization of human circulating and tissue-resident memory T cells. Immunity. 38: 187-197. (Also see preview article in same issue by Neuenhahn and Busch, D.H., “Whole body anatomy of human T cells”. Immunity. 38:10-12.)

2. Turner, D.L., Bickham, K.L., Farber, D.L. and Lefrancois, L. (2013) Splenic priming of virus-specific CD8 T cells following influenza infection. J. Virol. 87:4496-506.

3. Siracusa, M.C., Saenz, S.A., Tait Wojno, E.D., Kim, B.S., Osborne, L.C., Ziegler, C.G., Benitez, A.J., Ruymann, K.R., Farber, D.L., Sleiman, P.M., Hakonarson, H., Cianferoni, A., Wang, M.-L., Spergel, J.M., Comeau, M.R., and Artis, D. (2013) TSLP-mediated extramedullary hematopoiesis promotes allergic inflammation. Immunity. 39:1158-70.

4. Turner, D.L., Bickham, K.L., Thome, J.J.T., Kim, C., D’Ovidio, F., Wherry, E.J. and Farber, D.L. (2014) Lung resident niches for the generation and maintenance of influenza-specific memory T cells. Mucosal Immunology. 7:501-10.

5. Farber, D.L. , Yudanin, N.A. and Restifio, N.P. (2014) Human Memory T cells: generation, compartmentalization and homeostasis. Nature Reviews Immunology.14:24-35. (featured on cover)

6. Turner, D.L., Gordon, C.L. and Farber, D.L. (2014) Tissue resident T cells, in situ immunity and transplantation. Immunol. Reviews. 258:150-166.

7. Subramanian, M., Hayes, C.D., Thome, J.J., Thorp, E., Matsushima, G.K., Herz, J., Farber, D.L., Liu, K., Lakshmana, M. and Tabas, I. (2014) A Multiprotein Complex of Axl, LRP-1, and RanBP9 Mediates Dendritic Cell Efferocytosis and Antigen Cross-Presentation In Vivo. J. Clin. Invest. 124:1296-308.

8. Zens, K.D. and Farber, D.L. (2014) Memory CD4 T cell responses to influenza virus. Current Topics in Microbiology and Immunology. [Epub ahead of print].

9. Turner, D.L. and Farber, D.L. (2014) Mucosal resident memory CD4 T cells in protection and immunopathology. Front. Immunol. 5:331

10. Camirand, G., Wang, Y., Lu, Y. Wan, Y.Y., Lin, Y., Deng, S., Guz, G., Perkins, D.L., Finn, P.W., Farber, D.L., Flavell, R.A., Shlomchik, W.D., Lakkis, F.G., Rudd, C.E., and Rothstein, D.M. (2014) CD45 Ligation increases antigen-mediated expansion of regulatory T cell by promoting interactions with dendritic cells in vivo. J. Clin. Invest. In Press.

11. Thome, J.J.C., Yudanin, N.A., Ohmura, Y., Sathaliyawala, T., Kubota, M., Lerner, H., and Farber, D.L. (submitted) Multidimensional analysis of human T cells reveals tissue-dependent pathways for generation and maintenance.

12. Yu, M., Owens, D.M., Ghosh, S. and Farber, D.L. (submitted) Conditional PDK1 ablation promotes epidermal and T cell-mediated dysfunctions leading to inflammatory skin disease.